Business description not available.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 16M | 16M | 16M | 15M | 18M | 15M |
| Net Income | -5.9M | -5.9M | -4.8M | -5.8M | -5.0M | -3.6M |
| EPS | $-0.31 | $-0.31 | $-0.29 | $-0.39 | $-0.38 | $-0.28 |
| Free Cash Flow | -2.0M | -2.0M | -899K | -3.3M | -4.0M | -3.5M |
| ROIC | -35.7% | -30.3% | -18.8% | -23.2% | -22.1% | -13.7% |
| Gross Margin | - | - | - | - | - | - |
| Debt/Equity | 0.00 | 0.11 | 0.18 | 0.28 | 0.41 | 0.37 |
| Dividends/Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | -6.4M | -6.4M | -4.3M | -5.4M | -5.6M | -3.3M |
| Operating Margin | -39.6% | -39.6% | -26.3% | -34.8% | -32.2% | -22.3% |
| ROE | -23.1% | -23.1% | -21.8% | -26.9% | -24.9% | -15.8% |
| Shares Outstanding | 19M | 19M | 16M | 15M | 13M | 13M |
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 17M | 15M | 18M | 15M | 16M | 16M | 16M |
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT | -2.9M | -3.3M | -5.6M | -5.4M | -4.3M | -6.4M | -6.4M |
| Op. Margin | -17.3% | -22.3% | -32.2% | -34.8% | -26.3% | -39.6% | -39.6% |
| Net Income | -3.2M | -3.6M | -5.0M | -5.8M | -4.8M | -5.9M | -5.9M |
| Net Margin | -19.2% | -24.4% | -28.6% | -37.3% | -29.4% | -36.2% | -36.2% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | |||||||
| ROIC | -15.7% | -13.7% | -22.1% | -23.2% | -18.8% | -30.3% | -35.7% |
| ROE | -12.7% | -15.8% | -24.9% | -26.9% | -21.8% | -23.1% | -23.1% |
| ROA | -7.3% | -10.2% | -14.7% | -17.5% | -15.3% | -17.1% | -17.1% |
| Cash Flow | |||||||
| Op. Cash Flow | 180K | -3.2M | -3.5M | -2.5M | -668K | -1.7M | -1.7M |
| Free Cash Flow | -111K | -3.5M | -4.0M | -3.3M | -899K | -2.0M | -2.0M |
| Owner Earnings | -2.4M | -5.7M | -3.5M | -5.8M | -3.0M | -4.4M | -4.4M |
| CapEx | 291K | 308K | 545K | 821K | 231K | 297K | 297K |
| Maint. CapEx | 2.5M | 2.5M | 0 | 3.3M | 2.4M | 2.7M | 2.7M |
| Growth CapEx | 0 | 0 | N/A | 0 | 0 | 0 | 0 |
| D&A | 2.5M | 2.5M | 0 | 3.3M | 2.4M | 2.7M | 2.7M |
| CapEx/OCF | 161.5% | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | |||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Stock-Based Comp | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt Repayment | 515K | 3.7M | 386K | 960K | 2.1M | 1.1M | 1.1M |
| Balance Sheet | |||||||
| Net Debt | -11M | -3.6M | 271K | -2.9M | -3.7M | -8.5M | -11M |
| Cash & Equiv. | 21M | 12M | 8.0M | 9.0M | 7.7M | 11M | 11M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt/Equity | 0.42 | 0.37 | 0.41 | 0.28 | 0.18 | 0.11 | 0.00 |
| Interest Coverage | -7.1 | -3.7 | -18.2 | -5.0 | -3.9 | -7.7 | -7.7 |
| Equity | 25M | 23M | 20M | 21M | 22M | 26M | 26M |
| Total Assets | 44M | 36M | 34M | 33M | 32M | 34M | 34M |
| Total Liabilities | 19M | 13M | 14M | 12M | 9.5M | 8.8M | 8.8M |
| Intangibles | 4.8M | 4.9M | 5.0M | 4.5M | 4.6M | 4.6M | 4.6M |
| Retained Earnings | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Working Capital | 20M | 15M | 11M | 11M | 8.8M | 11M | 11M |
| Current Assets | 28M | 19M | 17M | 17M | 14M | 17M | 17M |
| Current Liabilities | 8.5M | 4.0M | 5.8M | 5.5M | 5.5M | 6.0M | 6.0M |
| Per Share Data | |||||||
| EPS | -0.36 | -0.28 | -0.38 | -0.39 | -0.29 | -0.31 | -0.31 |
| Owner EPS | -0.26 | -0.43 | -0.26 | -0.39 | -0.19 | -0.24 | -0.24 |
| Book Value | 2.82 | 1.74 | 1.52 | 1.45 | 1.34 | 1.36 | 1.36 |
| Cash Flow/Share | -0.08 | -0.09 | 0.00 | -0.17 | -0.15 | -0.17 | -0.17 |
| Dividends/Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Shares Out. | 9.0M | 13.2M | 13.3M | 14.8M | 16.4M | 18.8M | 18.8M |
| Valuation | |||||||
| P/E Ratio | -18.5 | -30.0 | -29.2 | -11.5 | -13.9 | -15.1 | -7.3 |
| P/FCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | 2.4 | 4.7 | 7.3 | 3.1 | 3.0 | 3.5 | 1.7 |
| Price/Sales | 3.6 | 7.3 | 8.3 | 4.3 | 4.1 | 5.5 | 2.7 |
| FCF Yield | -0.2% | -3.2% | -2.7% | -5.0% | -1.3% | -2.3% | -4.7% |
| Market Cap | 60M | 109M | 146M | 66M | 67M | 89M | 43M |
| Avg. Price | 5.88 | 6.11 | 12.47 | 5.05 | 3.79 | 5.16 | 2.30 |
| Year-End Price | 6.63 | 8.27 | 11.01 | 4.49 | 4.06 | 4.73 | 2.30 |
Optomed Plc passes 0 of 9 quality checks, indicating weak fundamentals.
Optomed Plc (OPTOMED-HE) has a 5-year average return on invested capital (ROIC) of -21.6%. This is below average and may indicate limited pricing power.
Optomed Plc (OPTOMED-HE) has a market capitalization of $43M. It is classified as a small-cap stock.
Optomed Plc (OPTOMED-HE) does not currently pay a regular dividend.
Optomed Plc (OPTOMED-HE) reported annual revenue of $16 million in its most recent fiscal year, based on SEC EDGAR filings.
Optomed Plc (OPTOMED-HE) has a net profit margin of -36.2%. The company is currently unprofitable.
Optomed Plc (OPTOMED-HE) generated $-2 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
Optomed Plc (OPTOMED-HE) has a debt-to-equity ratio of 0.11. This indicates a conservatively financed balance sheet.
Optomed Plc (OPTOMED-HE) reported earnings per share (EPS) of $-0.31 in its most recent fiscal year.
Optomed Plc (OPTOMED-HE) has a return on equity (ROE) of -23.1%. A negative ROE may indicate losses or negative equity.
The Ledger Terminal provides 6 years of financial data for Optomed Plc (OPTOMED-HE), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Optomed Plc (OPTOMED-HE) has a book value per share of $1.36, based on its most recent annual SEC filing.